chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 weeks after the 2nd dose vaccine, I started to have muscle cramps in my toes, feet, thighs, arms, sides and hands (mostly in my left hand). The majority of my cramps are located on the left side of my body (except my thighs where cramping is equal on both thighs). I went to see my doctor who recommended me to take magnesium and Pedialyte, which seems to help but not fully resolved. The pain level is about a 5/10 and the cramps in my thigh is so painful and can be a 10/10. I also started having intense hot flashes where I am drench in sweat. I did see a doctor who recommended hormones but I do not want to take any hormones. I get hot flashes pretty much every hour. The severity of the hot flashes can fog up my glasses. I am not taking any medications to help with the hot flashes.
About 7 minutes after receiving the second dose, patient was in the waiting room and felt a 'really rapid heart rate and felt it was difficult to breathe". Patient said it lasted about 3 minutes and she did not tell the paramedic or clinic staff that were in the waiting area.  After waiting 15 more minutes, she went to the car and felt "shaky and couldn't focus".  She waited another 15 minutes before leaving the parking lot to drive home, "feeling a little funny". Dose 1 was on 01/22/2021.  When I spoke with patient at 16:00 on 02/19/2021, she was home and feeling better. She feels her heart rate and breathing are normal, now only noticing a dry, sore throat. She does not feel she needs to seek medical care.
Decreased appetite and "a little lethargy" afternoon early evening day of vaccines, cried 1030-11 PM. Felt hot T 105. Gave Tylenol, tepid bath, pacifier - then "settled down" and by next AM was "fine" afebrile, no other seizure activity noted.
13 days post smallpox vax developed blisters on upper left lip. Area spread rapidly by day 14 and lip swollen. Called PMD for evaluation but refused to see her so referred to another hospital ER for testing. Smear of lesion showed acute inflam. cells - no viral cytopatoic effect. Day 16 showed much improved.
I have left eye pain for one month. I scaled the pain to be a 6. I went to see an optometrist. They found nothing but dry eye. I knew this 5 years ago, but it did not cause pain. I went to another doctor, after my 2nd dose, the eye pain was worse. It lasted much longer, gradually it goes away and comes back. It is not as bad anymore. I also have chest palpitations and pain; this was 10 days after my 2nd dose. The position related, when I sit and lean forward, I feel pain. I feel like it was puerilities, the feeling of pain is happening but, not as often. They doctors are saying I have premature heartbeat. I have never had this before and I have no family history of heart problems. I also have a rash on both hands and joint pain on left ankle front side. This is not normal for me. I had seen a neurologist due to neck pain.
This spontaneous report as received from a physician refers to a patient of unknown age. The patient had no pertinent medical history and no drug reactions or allergies. The patient was vaccinated with PNEUMOVAX23 (lot number reported as H013847, expired date 15-MAR-2014) (dose, frequency and injection site were not reported) intramuscular injection on an unknown date in October 2012 (within the past ten days). No other co-suspects were reported. There was no concomitant medication. The physician reported that he saw the patient day after vaccination and that the patient presented with swelling of the upper arm in the mid-bicep region, warmth, (the area was hot to the touch"), tenderness and pain. The patient might have had a low-grade fever. The patient started on unspecified antibiotics and mild analgesics. The patient was recovering at the time of report. There was no laboratory diagnostics studies performed. The patient had an office visit for medical attention. Physician requests a lot check for the PNEUMOVAX23. This is one of several reports received from the same source. Additional information has been requested.
got the 1st dose in last march but after a week she tested positive with COVID virus; This is a spontaneous report from a contactable consumer (patient) from a Pfizer sponsored program. A female patient of an unspecified age received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6198), dose 1 via an unspecified route of administration on 02Mar2021 as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On 08Mar2021, after a week later the patient tested positive with COVID virus got diagnosed with Covid-19 and had light symptoms. On 10Mar2021, Patient received monoclonal antibodies for the Covid-19. she undergo a with an body fluid infusion that was advised by her doctor, and when she ask about the 2nd dose when will be getting that she was informed not to get it for 3 months. and right now she want to know if she can go ahead and do that with facility where she got the 1st dose or she will be stating all over again? The patient underwent lab tests and procedures which included Covid test: positive on 08Mar2021. Therapeutic measures were taken with monoclonal antibodies and body fluid infusion as a result of covid-19. The outcome of event was unknown.
A sales representative reported that a 15 month old child received the first dose of Prevnar along with Act-Hib on 4/4/00. The following day, the child developed an injection site reaction characterized by redness, swelling and rash and a "low-grade" fever. The child was seen by the physician on 4/5/00 who prescribed applications of ice to the affected thigh. Additional information received from the physician on 5/2/00 supplied pt information and lot number. The reporter noted a change in the date of vaccine administration and onset of adverse events. Both sides of administration were in the left thigh.
Patient was taking a shower the morning following vaccination.  She reported getting out of the shower and then waking up on the floor across the room with a bump on her head.  She does not remember what happened in between getting out of the shower and then waking up on the floor.   She reports being taken to the ER in an ambulance and having numerous tests and imaging performed in the hospital, however the cause of her fall could not be determined.   Prior to her fall she said her arm was sore but she did not feel any other symptoms.  She did report feeling slightly dizzy in the shower after turning around but the feeling was fleeting and she felt fine the rest of the shower.  She was not sure if the shingles vaccine was the cause but she requested the event be documented and submitted.
On March 17, 2008, mother and father was awaken by a cry that was described as "not normal" coming from their 11 month old daughter's room. They found their daughter asleep but crying with her eyes closed and no other movement was noted. When approaching the child, they suspected that she was having a nightmare so the father proceeded to pick up the child from the crib. The child did not respond to neither one of the parents' voices and the child had no muscle tone in her arms, legs, or neck. The child continued to cry with eyes closed and no muscle tone. The parents noted that the child was breathing normally but her face and lips were swollen. The child remained in that condition for a total of 45 minutes. // 2nd event// April 2, 2008: Child was found in the crib at 7:00 am having full "body convulsions" with eyes open and non-responsive to parents. Again, face and lips looked abnormally swollen but breathing was regular. Father caught incident on tape to report to the doctor in the emergency room. Incident lasted for 10 minutes and child responded by crying for a minute and then was laid down on the parents bed for further examination of child. Mother noticed that the child had no muscle tone from the neck down. Child was alert, normal baby talking, smiling and laughing took place but child could not move arms or legs. Child regained full muscle tone an hour later upon reaching emergency room. Doctor diagnosed child with having seizures and proceeded to write precription for Diastat. Neurologist prescribed Keppra. Parents noted that these two incidents happened only when child was drinking whole milk. Doctors stated that a milk allergy could not have caused her seizure-like incidents. If milk could not have caused incident then the child's vaccination could have caused this adverse action. Vaccine was given less than a month of the first incident.// 4/10/08-records received from ED for DOS 03/17/08-DX: Altered level of consciousness. C/O acting differently, lethargic, weak cry, irritable. Appeared clenched.
Patient developed some swelling in neck 22 minutes after vaccination while driving home. He did not seek any immediate medical attention, but gave himself an epinephrine injection several hours later with full resolution of symptoms
Pregnant (20 weeks gestation); Redness on injection site; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant (20 weeks gestation)) and VACCINATION SITE ERYTHEMA (Redness on injection site) in a 31-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (one week prior use.) on 10-Aug-2020. Concurrent medical conditions included High cholesterol (The same) since 2018, Drug allergy (claritin for allergy) and Bone disorder (vitamin D for bones). Concomitant products included CLARITHROMYCIN from an unknown date to 08-Nov-2020 for Allergy, VITAMIN D [VITAMIN D NOS] from 08-Dec-2020 to an unknown date for Bone disorder, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and FISH OIL for an unknown indication.    On 09-Feb-2021 at 4:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 07-Oct-2020 and the estimated date of delivery was 14-Jul-2021. On 09-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant (20 weeks gestation)) and VACCINATION SITE ERYTHEMA (Redness on injection site). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  seventeenth week of the pregnancy.  On 09-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant (20 weeks gestation)) had resolved. On 12-Feb-2021, VACCINATION SITE ERYTHEMA (Redness on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Pregnancy test was positive on 10-Nov-2020.; Reporter's Comments: This is a case of product exposure during pregnancy with vaccination site erythema for this 31-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Information has been received from a physician concerning a female (age not reported) who on 09-JUL-2008 was vaccinated with the first 0.5 mL dose of GARDASIL vaccine (yeast) (lot not reported). "Soon after receiving the second dose of the vaccine the patient experienced injection site red welt and ongoing headache that will not go away. The patient's injection site red welt and ongoing headache that will not go away persisted. Additional information has been requested.
By 5PM day of shot 2/2 I felt lethargic, had chills, and has temperature of 99.8 at 7PM. Next day (2/3) my temperature was low, 97.5, felt very lethargic, and had a headache. All symptoms were gone by next morning 2/4.
Extremely dry mouth. Inflamed dry throat. Shallow breath. Rash that covers most the body, but is worse around the chest and neck. Fatigue. Hard to breathe. Red; hot; itchy rash. Waking up at night gasping for air. Finally given steroids. I am currently taking them to see if it calms down.
Patient was admitted on 1/7/2022 because of fatigue.  She does have a history of breast cancer on chemotherapy and COVID-19.  Patient was a diagnosis COVID-19 pneumonia on 01/05/2021 with symptom onset on 01/03/2021.  She was discharged on doxycycline.  She had been at progressively weaker and developed nausea and fatigue.  On arrival in the emergency room she was satting 89% on room air and uses 2 L nasal cannula at home.  She has received COVID-19 vaccination and booster.  She is currently undergoing chemotherapy for breast cancer.  On arrival in the emergency room D-dimer was 1368 LDH 296 lactic acid 1.4.  Chest x-ray revealed mild scattered opacities the lung base primarily likely due to atelectasis versus evolving infiltrates which appears slightly more prominent compared to prior studies.  She does complain of dysphagia and feels like things get stuck.  She was started on IV Decadron and Remdesivir was discussed with her.  She is currently on nasal cannula oxygen at 4 L. She is due to have another course of chemotherapy next week in she was told that she this will likely need to be postponed.  Her oncologist is Dr. "PRIVATE".     Her oxygen was able to be weaned down to 3 L nasal cannula.  She is normally on 2 L at home.  She felt that she was stable for discharge home on 1/10.  She was treated with dexamethasone and azithromycin.  Remdesivir will be discontinued and she will be sent home with the Covid care kit.
Pt had a rash appear one day after the vaccine that lasted 4 days. Rash reappeared in the same spot 2 weeks later.
left arm hurts; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (left arm hurts) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthmatic.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (left arm hurts). At the time of the report, PAIN IN EXTREMITY (left arm hurts) outcome was unknown.            No concomitant information provided, did not want to give the  list of his medications.  No treatment information provided. Patient had completed Moderna primary series, received his booster dose.
Felt foggy in the head; Vaccintation site pain; Vaccination site bruising; tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt foggy in the head), VACCINATION SITE PAIN (Vaccintation site pain), VACCINATION SITE BRUISING (Vaccination site bruising) and FATIGUE (tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided.     On 03-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Felt foggy in the head), VACCINATION SITE PAIN (Vaccintation site pain), VACCINATION SITE BRUISING (Vaccination site bruising) and FATIGUE (tired). At the time of the report, FEELING ABNORMAL (Felt foggy in the head) and FATIGUE (tired) outcome was unknown and VACCINATION SITE PAIN (Vaccintation site pain) and VACCINATION SITE BRUISING (Vaccination site bruising) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 30-Sep-2021: The follow up document contains no new information.
Eyes have been burning burning badly since she has received the vaccine; Having difficulty with her vision; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (Eyes have been burning burning badly since she has received the vaccine) and VISUAL IMPAIRMENT (Having difficulty with her vision) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Food allergy. Concomitant products included APIXABAN (ELIQUIS), LISINOPRIL, LEVOTHYROXINE, CARVEDILOL, ROSUVASTATIN, CALCITRIOL, MORPHINE and VITAMINS NOS for an unknown indication.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced EYE IRRITATION (Eyes have been burning burning badly since she has received the vaccine) and VISUAL IMPAIRMENT (Having difficulty with her vision). At the time of the report, EYE IRRITATION (Eyes have been burning burning badly since she has received the vaccine) and VISUAL IMPAIRMENT (Having difficulty with her vision) had not resolved.            Other concomitant medications included: OTC vitamins The patient reported that she was having a lot of trouble to the point that she was having difficulty with her vision. She was not sure if this was due to the vaccine. Treatment for the events included: Eye drops.
I received the shot on 9/27/22. The next morning I woke up with tingling and numbness in my left arm down to my fingertips. It persisted and on 10/1/22 I went to Urgent Care to have it evaluated. They said to keep watching it thinking it was an inflammed lymph node pressing on a nerve and told me to take Ibuprofen. Another week later and I still have the numbness and tingling in my arm/fingers even after having taken Ibuprofen on and off throughout this past week.
Mom states 2-3 hrs after vaccine admin right arm started swelling. Exam 5/10/05. R arm/deltoid edematous, warm to touch, erythema of tender
rash started. ring around injection site. body, upper thighs. Warm, red, slightly swollen, itchy. a little sore. No wheezing, shortness of breath, tongue or throat swelling. No fever, cough, runny nose or sore throat. Did not use any new medications or products. No sick contact. Tried hydrocortisone cream.
This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION SITE PRURITUS (experienced raised, pink, itchy, and painful welts in the area of his Moderna shot),  in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 041H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 07-Dec-2022, the patient experienced VACCINATION SITE PRURITUS (experienced raised, pink, itchy, and painful welts in the area of his Moderna shot),      Concomitant product use was not provided by the reporter.
contracted COVID 19; contracted COVID 19; This is a spontaneous report from a contactable consumer or other non hcp via Pfizer sponsored program support. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), via an unspecified route of administration on an unspecified date as unknown, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, the patient was contracted with COVID19. HCP asked for lot information. Outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Patient was given 1st dose of Moderna vaccine, Lvn supervisor Monitored patient for 45 minutes after injection in lobby. no side effects noted. Supervisor informed mother of vaccine administration and will follow up in the upcoming days and set up a follow up appt. with PCP. Informed mother if patient begins to have any adverse reactions to the vaccine do not hesitate to go to urgent care or local hospital.
No Additonasl AE's a; improperly stored dose of PROQUAD was administered to a patient.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant therapies was provided.   On 01-AUG-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) rHA, lot #U031561, expiration date: 06-APR-2023 (strength, exact dose and route of administration were not provided) for prophylaxis (Product storage error). No details regarding the storage conditions were provided. No adverse events were reported (No adverse event).
constant itch/ Not always in the same location but a handful of spots; This is a spontaneous report received from a contactable consumer (patient) reported a male patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified route single dose for COVID-19 immunization on 03Apr2021. Medical history and concomitant medication were not reported. Since the first vaccination, the patient had almost a constant itch. Not always in the same location but a handful of spots. No rash present but the itching was persistent. Outcome of the event was not resolved.  No follow-up attempts are needed. No further information is expected.
Swelling, pain and numbness of lt jaw beginning 3 ds post spv. Sxs began with tingling and numbness in left face and the next day lt side of face was swollen. Now has palpable "lump" on lt face. SPV given on lt deltoid. Had axillary LAD. but no cervical LAD. Attempt made to drain lesion but no fluid obtained. Low grade fever, which was now resolved.
3 Large blotches on the left arm after 3rd shot/Itchy blotches on left arm  after 3rd shot; Itching left arm injection site after 3rd shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching left arm injection site after 3rd shot) and RASH MACULAR (3 Large blotches on the left arm after 3rd shot/Itchy blotches on left arm  after 3rd shot) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. BU0C21A, 029M19A and 007M20X) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Sep-2021, the patient experienced VACCINATION SITE PRURITUS (Itching left arm injection site after 3rd shot). On 15-Sep-2021, the patient experienced RASH MACULAR (3 Large blotches on the left arm after 3rd shot/Itchy blotches on left arm  after 3rd shot). At the time of the report, VACCINATION SITE PRURITUS (Itching left arm injection site after 3rd shot) and RASH MACULAR (3 Large blotches on the left arm after 3rd shot/Itchy blotches on left arm  after 3rd shot) had not resolved.            Concomitant product use was unknown by the reporter. Treatment information was not provided. The patient states that she did not contact her doctor and she was not using any medication but placed Ice on it once.   This case was linked to MOD-2021-320257 (Patient Link).
distributor of vax reports that had been contacted by MD regarding 3pts who had been immunized recently w/pnu-immune & exp adverse events (sx unspecified);no further clinical details provided;